Brazil represents one of the largest pharmaceutical markets in the world, ranking among the top ten globally and leading the Latin American region. Over the past decade, the sector has witnessed steady growth, driven by increasing healthcare investments, rising disposable incomes, and a growing middle class. As the world’s sixth-most populous country, Brazil offers a
Tag Archives: brazil
Navigating the complex regulatory environment is a constant challenge in every country. Between evolving standards, stringent documentation requirements, and the need for timely submissions, keeping up can overwhelm even the most efficient teams. Nowhere is this more true than in Brazil, where ensuring compliance with ANVISA (Agência Nacional de Vigilância Sanitária) requires constant attention and
The pharmaceutical industry in Brazil continues to experience rapid growth, driven by demand for innovative therapies and increasing healthcare access. While that growth presents new opportunities for pharmaceutical companies, navigating the evolving regulatory environment poses significant challenges for companies seeking to bring new products to market. At the heart of the process lies ANVISA (Agência
The Scigeniq team was present in force at the FCE Pharma conference earlier in June. The conference was huge and underscored the exciting trends and developments in the Latin American Pharma market. Focused on the Pharma Industry FCE Brazil is a major trade show and conference focused on the pharmaceutical industry. Held annually, the event
The pharmaceutical industry in Brazil and Latin America has undergone a remarkable transformation over the past few decades. Twenty years ago, the industry mainly consisted of multinational companies importing products and small family firms marketing local formulations of generic drugs. Today, the market is driven by fast-growing local companies that offer a wide range of
The pharmaceutical industry in Latin America has grown substantially in the last decade. In the decade ending in 2018, the value of medicine purchases in pharmacies more than doubled in Latin America and the Caribbean. The market grew from US$34.3 billion in 2008 to US$69.5 billion in 2018. The region accounts for 6.3 percent of